Trade Medical Properties Reit - MPW CFD

Add to favourite

4.97

4.63%

0.06

Low: 4.69

High: 4.97

Market Trading Hours* (UTC) Opens on Friday at 13:30

Mon - Fri: 13:30 - 20:00

Summary
Historical Data
Events
Income Statement
Balance Sheet
Cash Flow

Trading сonditions

Spread

0.06

Long position overnight fee

-0.026179%

Short position overnight fee

0.003957%

Overnight fee time

21:00 (UTC)

Min traded quantity

Currency

USD

Margin

Stock exchange

United States of America

Commission on trade

*Information provided by Capital.com

Medical Properties Trust Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats

Prev. Close*	4.75
Open*	4.71
1-Year Change*	-44.52%
Day's Range*	4.69 - 4.97
52 wk Range	2.92-14.00
Average Volume (10 days)	43.68M
Average Volume (3 months)	411.27M
Market Cap	1.84B
P/E Ratio	-100.00K
Shares Outstanding	599.00M
Revenue	1.37B
EPS	-0.06
Dividend (Yield %)	19.544
Beta	1.16
Next Earnings Date	Feb 21, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

Last Week
Last Month
Last Year
Last two Years
Max

Daily
Weekly
Monthly

Date	Close	Change	Change (%)	Open	High	Low
Apr 18, 2024	4.97	0.21	4.41%	4.76	4.98	4.67
Apr 17, 2024	4.75	0.07	1.50%	4.68	4.83	4.63
Apr 16, 2024	4.59	-0.01	-0.22%	4.60	4.77	4.57
Apr 15, 2024	4.72	-0.01	-0.21%	4.73	5.28	4.54
Apr 12, 2024	3.96	-0.07	-1.74%	4.03	4.11	3.92
Apr 11, 2024	4.07	-0.02	-0.49%	4.09	4.12	3.95
Apr 10, 2024	4.10	0.08	1.99%	4.02	4.11	3.91
Apr 9, 2024	4.25	0.18	4.42%	4.07	4.26	4.06
Apr 8, 2024	4.06	-0.02	-0.49%	4.08	4.12	4.02
Apr 5, 2024	4.03	-0.11	-2.66%	4.14	4.16	4.02
Apr 4, 2024	4.20	-0.08	-1.87%	4.28	4.41	4.20
Apr 3, 2024	4.23	0.01	0.24%	4.22	4.27	4.14
Apr 2, 2024	4.28	-0.12	-2.73%	4.40	4.44	4.26
Apr 1, 2024	4.48	-0.21	-4.48%	4.69	4.69	4.43
Mar 28, 2024	4.68	0.02	0.43%	4.66	4.80	4.59
Mar 27, 2024	4.69	0.63	15.52%	4.06	4.76	3.98
Mar 26, 2024	3.95	-0.01	-0.25%	3.96	4.05	3.90
Mar 25, 2024	3.95	-0.17	-4.13%	4.12	4.18	3.93
Mar 22, 2024	4.07	-0.17	-4.01%	4.24	4.30	4.05
Mar 21, 2024	4.23	-0.04	-0.94%	4.27	4.37	4.15

Medical Properties Reit Events

Time (UTC)	Country	Event
Friday, April 19, 2024
Time (UTC) 12:00	Country US	Event Medical Properties Trust Inc Medical Properties Trust Inc Forecast - Previous -
Time (UTC) 12:00	Country US	Event Medical Properties Trust Inc Medical Properties Trust Inc Forecast - Previous -
Thursday, April 25, 2024
Time (UTC) 12:30	Country US	Event Q1 2024 Medical Properties Trust Inc Earnings Release Q1 2024 Medical Properties Trust Inc Earnings Release Forecast - Previous -
Friday, May 24, 2024
Time (UTC) 16:30	Country US	Event Medical Properties Trust Inc Annual Shareholders Meeting Medical Properties Trust Inc Annual Shareholders Meeting Forecast - Previous -
Thursday, May 30, 2024
Time (UTC) 15:30	Country US	Event Medical Properties Trust Inc Annual Shareholders Meeting Medical Properties Trust Inc Annual Shareholders Meeting Forecast - Previous -
Tuesday, August 6, 2024
Time (UTC) 12:30	Country US	Event Q2 2024 Medical Properties Trust Inc Earnings Release Q2 2024 Medical Properties Trust Inc Earnings Release Forecast - Previous -

View all events

Annual
Quarterly

	2022	2021	2020	2019	2018
Total revenue	1542.85	1544.67	1249.24	854.197	784.522
Revenue	1542.85	1544.67	1249.24	854.197	784.522
Cost of Revenue, Total	39.997	32.798	18.89	18.192	9.237
Gross Profit	1502.85	1511.87	1230.35	836.005	775.285
Total Operating Expense	807.543	505.985	439.804	293.747	271.33
Selling/General/Admin. Expenses, Total	166.194	151.938	137.663	102.211	80.086
Depreciation / Amortization	332.977	321.249	264.245	152.313	133.083
Unusual Expense (Income)	268.375	0	19.006	21.031	48.924
Operating Income	735.308	1038.68	809.434	560.45	513.192
Interest Income (Expense), Net Non-Operating	-318.236	-366.555	-336.491	-227.885	-223.274
Gain (Loss) on Sale of Assets	536.755	52.471	-2.833	41.56	719.392
Other, Net	5.892	6.288	-6.782	-0.345	10.094
Net Income Before Taxes	959.719	730.888	463.328	373.78	1019.4
Net Income After Taxes	903.819	656.94	432.272	376.401	1018.48
Minority Interest	-1.222	-0.919	-0.822	-1.717	-1.792
Net Income Before Extra. Items	902.597	656.021	431.45	374.684	1016.68
Net Income	902.597	656.021	431.45	374.684	1016.68
Total Adjustments to Net Income	-1.602	-2.161	-2.105	-2.308	-3.685
Income Available to Common Excl. Extra. Items	900.995	653.86	429.345	372.376	1013
Income Available to Common Incl. Extra. Items	900.995	653.86	429.345	372.376	1013
Diluted Net Income	900.995	653.86	429.345	372.376	1013
Diluted Weighted Average Shares	598.837	590.139	530.461	428.299	366.271
Diluted EPS Excluding Extraordinary Items	1.50457	1.10798	0.80938	0.86943	2.76571
Dividends per Share - Common Stock Primary Issue	1.16	1.12	1.08	1.02	1
Diluted Normalized EPS	1.08251	1.02806	0.84779	0.83827	0.93685
Total Extraordinary Items
Dilution Adjustment				0

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Total revenue	306.576	337.395	350.211	380.486	352.339
Revenue	306.576	337.395	350.211	380.486	352.339
Cost of Revenue, Total	6.483	24.676	7.11	7.699	8.265
Gross Profit	300.093	312.719	343.101	372.787	344.074
Total Operating Expense	126.145	424.683	222.232	400.421	127.457
Selling/General/Admin. Expenses, Total	38.11	35.604	41.724	42.893	37.319
Depreciation / Amortization	77.802	364.403	83.86	81.454	81.873
Unusual Expense (Income)	3.75	0	89.538	268.375
Operating Income	180.431	-87.288	127.979	-19.935	224.882
Interest Income (Expense), Net Non-Operating	-94.583	-93.062	-86.302	-84.853	-76.593
Gain (Loss) on Sale of Assets	-0.02	0.167	0.062	-0.033	68.795
Other, Net	41.125	-10.512	-5.166	-20.106	23.515
Net Income Before Taxes	126.953	-190.695	36.573	-124.927	240.599
Net Income After Taxes	116.895	-42.433	33.03	-140.212	222.02
Minority Interest	-0.185	0.396	-0.236	-0.262	-0.227
Net Income Before Extra. Items	116.71	-42.037	32.794	-140.474	221.793
Net Income	116.71	-42.037	32.794	-140.474	221.793
Total Adjustments to Net Income	-0.311	-0.469	-0.515	-0.567	-0.288
Income Available to Common Excl. Extra. Items	116.399	-42.506	32.279	-141.041	221.505
Income Available to Common Incl. Extra. Items	116.399	-42.506	32.279	-141.041	221.505
Diluted Net Income	116.399	-42.506	32.279	-141.041	221.505
Diluted Weighted Average Shares	598.553	598.344	598.31	598.052	599.339
Diluted EPS Excluding Extraordinary Items	0.19447	-0.07104	0.05395	-0.23583	0.36958
Dividends per Share - Common Stock Primary Issue	0.15	0.29	0.29	0.29	0.29
Diluted Normalized EPS	0.20027	-0.07122	0.18901	0.05589	0.26366

Annual
Quarterly

	2022	2021	2020	2019	2018
Cash and Short Term Investments	235.668	459.227	549.884	1462.29	820.868
Cash & Equivalents	235.668	459.227	549.884	1462.29	820.868
Total Receivables, Net	787.166	728.522	490.462	334.231	220.848
Total Assets	19658	20519.8	16829	14467.3	8843.64
Property/Plant/Equipment, Total - Net	17693.5	16440.1	13512.6	10877.9	6700.85
Property/Plant/Equipment, Total - Gross	15917.8	17425.8	14337.9	11438.1	7165.83
Accumulated Depreciation, Total	-1193.31	-993.1	-833.529	-570.042	-464.984
Note Receivable - Long Term	394.874	1384.88	904.576	576.189	399.053
Other Assets, Total	546.765	326.021	247.835	289.733	702.024
Payable/Accrued	621.324	607.792	438.75	291.489	204.325
Notes Payable/Short Term Debt	0	0	0	0	0
Other Current Liabilities, Total	42.6	70.851	52.831	29.626	27.524
Total Liabilities	11065.2	12079.6	9490.48	7439.28	4296.54
Total Long Term Debt	10270.3	11284.7	8867.39	7025.61	4037.39
Long Term Debt	10268.4	11282.8	8865.46	7023.68	4037.39
Minority Interest	1.569	5.483	5.325	0.107	13.83
Other Liabilities, Total	27.727	25.563	36.177	16.098	13.467
Total Equity	8592.84	8440.19	7338.53	7028.05	4547.11
Common Stock	0.597	0.597	0.541	0.518	0.371
Additional Paid-In Capital	8535.14	8564.79	7461.5	7008.2	4442.95
Retained Earnings (Accumulated Deficit)	116.285	-87.691	-71.411	83.012	162.768
Treasury Stock - Common		-0.777	-0.777	-0.777	-0.777
Other Equity, Total	-59.184	-36.727	-51.324	-62.905	-58.202
Total Liabilities & Shareholders’ Equity	19658	20519.8	16829	14467.3	8843.64
Total Common Shares Outstanding	597.476	596.814	541.419	517.522	370.637
Total Inventory					0
Long Term Investments		1181.03	1123.62	926.99
Accrued Expenses	101.592	85.217	90.006	76.353
Capital Lease Obligations	1.938	1.937	1.935	1.932
Preferred Stock - Non Redeemable, Net	0	0

	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022
Cash and Short Term Investments	340.058	324.05	302.321	235.668	299.171
Cash & Equivalents	340.058	324.05	302.321	235.668	299.171
Total Receivables, Net	788.761	779.584	810.911	787.166	710.082
Total Assets	19004.9	19204.4	19650.2	19658	19043.4
Property/Plant/Equipment, Total - Net	16858.7	17113.9	17512.2	17667.3	17115
Property/Plant/Equipment, Total - Gross	14868.4	15065.8	15903	15917.8	15353.8
Accumulated Depreciation, Total	-1315.22	-1251.17	-1207.7	-1193.31	-1088.91
Long Term Investments
Note Receivable - Long Term	459.03	377.003	445.878	394.874	317.8
Other Assets, Total	558.291	609.881	578.853	572.99	601.387
Payable/Accrued	375.888	444.926	595.269	621.324	569.017
Notes Payable/Short Term Debt	0	0	0	0	0
Other Current Liabilities, Total	154.218	157.411	144.092	146.13	146.438
Total Liabilities	10720.4	10890.6	11208.5	11065.2	10211.6
Total Long Term Debt	10157.1	10237.6	10438.2	10268.4	9476.14
Long Term Debt	10157.1	10237.6	10438.2	10268.4	9476.14
Minority Interest	0.887	0.902	1.574	1.569	1.466
Other Liabilities, Total	32.28	49.766	29.391	27.727	18.569
Total Equity	8284.53	8313.81	8441.68	8592.84	8831.78
Common Stock	0.598	0.598	0.598	0.597	0.599
Additional Paid-In Capital	8558.77	8547.83	8541.41	8535.14	8537.14
Retained Earnings (Accumulated Deficit)	-215.058	-241.301	-25.413	116.285	433.339
Treasury Stock - Common
Other Equity, Total	-59.778	6.68	-74.919	-59.184	-139.301
Total Liabilities & Shareholders’ Equity	19004.9	19204.4	19650.2	19658	19043.4
Total Common Shares Outstanding	598.444	598.344	598.302	597.476	598.983
Preferred Stock - Non Redeemable, Net	0	0	0	0	0

Annual
Quarterly

	2022	2021	2020	2019	2018
Net income/Starting Line	903.819	656.94	432.272	376.401	1018.48
Cash From Operating Activities	739.01	811.656	617.636	494.117	449.088
Cash From Operating Activities	345.577	333.781	275.953	156.575	141.492
Deferred Taxes	0.043	-12.697	19.819	5.581	0.145
Non-Cash Items	-423.556	-192.184	-107.81	-91.984	-733.877
Cash Interest Paid	353.838	326.406	309.92	211.163	221.779
Changes in Working Capital	-86.873	25.816	-2.598	47.544	22.851
Cash From Investing Activities	396.056	-3858.41	-2946.77	-4883.96	564.178
Capital Expenditures	-1442.2	-5417.96	-4317.53	-4649.39	-1484.96
Other Investing Cash Flow Items, Total	1838.26	1559.55	1370.76	-234.565	2049.14
Cash From Financing Activities	-1342.52	2947.61	1401.07	5041.88	-345.87
Financing Cash Flow Items	-88.554	-36.674	-20.641	-62.317	-24.22
Total Cash Dividends Paid	-698.535	-643.473	-567.969	-411.697	-363.906
Issuance (Retirement) of Stock, Net	-17.94	1051.23	411.101	2533.21	94.239
Issuance (Retirement) of Debt, Net	-537.494	2576.53	1578.58	2982.69	-51.983
Foreign Exchange Effects	-12.887	4.662	16.441	-6.478	-17.218
Net Change in Cash	-220.344	-94.487	-911.622	645.566	650.178

	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022
Net income/Starting Line	33.03	903.819	1044.03	822.011	631.947
Cash From Operating Activities	135.648	739.01	557.915	344.016	179.387
Cash From Operating Activities	87.586	345.577	260.717	176.077	88.76
Deferred Taxes	0.6	0.043	-8.185	-5.347	-7.646
Non-Cash Items	33.135	-423.556	-670.198	-582.6	-499.554
Cash Interest Paid	116.436	353.838	285.417	209.445	111.012
Changes in Working Capital	-18.703	-86.873	-68.45	-66.125	-34.12
Cash From Investing Activities	17.178	396.056	858.311	534.128	879.034
Capital Expenditures	-86.192	-1442.2	-1070.03	-1037.41	-760.91
Other Investing Cash Flow Items, Total	103.37	1838.26	1928.34	1571.54	1639.94
Cash From Financing Activities	-89.125	-1342.52	-1543.69	-1062.72	-1263.82
Financing Cash Flow Items	-8.464	-88.554	-85.492	-43.542	-19.117
Total Cash Dividends Paid	-176.58	-698.535	-524.536	-350.519	-176.494
Issuance (Retirement) of Stock, Net		-17.94	0	0	0
Issuance (Retirement) of Debt, Net	95.919	-537.494	-933.661	-668.661	-1068.2
Foreign Exchange Effects	2.927	-12.887	-29.739	-14.786	-4.721
Net Change in Cash	66.628	-220.344	-157.202	-199.364	-210.116

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission

Leverage

1:1

20
100
500
1000
10000

Investment

Trade size (Leverage x Investement):

Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Medical Properties Company profile

Founded in 2003, Medical Properties Trust, Inc. bridges the gap between the growing demand for high-quality healthcare and the ability to deliver it cost-effectively. Specialising in acute-care, community and rehabilitation hospitals, this healthcare real estate investment trust (REIT) provides operators access to capital for facility improvements, technology upgrades, staff additions and new construction through long-term net leases of real estate assets. By reinvesting non-earning assets into operations, MPT clients are able to participate in the growth of the largest sector of the U.S. economy. The company’s facilities include acute care hospitals, inpatient rehabilitation hospitals, long-term acute care hospitals, and other medical and surgical facilities. The company’s properties are located in various states of the United States, the United Kingdom, Italy, Germany and Spain. To learn the latest Medical Properties share price, follow Capital.com.

Industry:

Healthcare REITs

1000 Urban Center Drive, Suite 501
BIRMINGHAM
ALABAMA 35242
US

Income Statement

Annual
Quarterly

News

Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported

Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.

07:56, 17 April 2024

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024